• Pseudo-UTP and Pseudouridine in RNA Research

  2026-10-09

  Pseudo-UTP is a pseudouridine-containing nucleotide of interest in RNA synthesis, innate immune recognition, and translational research. Current evidence supports important biological questions but does not justify treating supplier claims about stability, translation, or reduced immunogenicity as universal outcomes across RNA designs, cell types, or clinical applications.

• DNA Nanosystems for mRNA Delivery: Review Insights

  2026-10-09

  The review by Tang, Xiao, and Yang examines how programmable DNA architectures could address persistent barriers in mRNA delivery. Its central contribution is a framework comparing branched DNA nanohydrogels, nucleic acid origami, and polymer–DNA hybrids by cargo handling, structural control, release behavior, and biomedical relevance, while emphasizing that most evidence remains preclinical and system-dependent.

• DRP1, Mitochondrial Fission, and Hyperoxia in ATII Cells

  2026-10-08

  Sun et al. connect hyperoxia in alveolar type II cells with increased DRP1-associated mitochondrial fission and a shift toward aerobic glycolysis. Their tissue, primary-cell, and pharmacological evidence supports a mechanistic relationship relevant to bronchopulmonary dysplasia, while the model remains preclinical and does not establish clinical efficacy.

• Biotin-16-UTP Product Overview

  2026-10-08

  Biotin-16-UTP (SKU B8154) is a supplier-described biotin-labeled uridine triphosphate analog for conceptual use in in vitro transcription RNA labeling. No matched paper evidence was provided, so performance, compatibility, and assay outcomes cannot be independently assessed.

• Lithium, Exosomal Wnt10a, and Bone Regeneration

  2026-10-07

  The 2024 ACS Applied Materials & Interfaces study identifies a mechanistic link between lithium exposure, Rab11a-dependent exosomal Wnt10a secretion, and activation of the Wnt/β-catenin signaling pathway in bone mesenchymal stem cells. Its findings suggest that lithium-engineered exosomes and GelMA-based delivery systems may improve osteogenic activity, while also highlighting important limits when translating pathway observations into therapeutic claims.

• Mubritinib (TAK 165): Mechanism and Evidence

  2026-10-07

  Mubritinib, also known as TAK 165, is best interpreted as a mitochondrial complex I inhibitor with context-dependent activity in AML and KSHV-positive PEL models. The available dossier supports mechanistic and preclinical research use, but it does not establish clinical efficacy or provide enough assay detail for direct protocol replication.

• Microbiota–AhR Axis in Ulcerative Colitis Repair

  2026-10-06

  Li et al. describe a microbiota–tryptophan metabolite–AhR–intestinal stem cell axis that may explain how Huangqin decoction supports mucosal repair in a mouse model of ulcerative colitis. The study combines microbiome, metabolite, pathway, and epithelial differentiation evidence, while leaving important questions about cell-specific causality and translation to human disease.

• Homoharringtonine and SARS-CoV-2: Study Evidence

  2026-10-06

  The reference study evaluates homoharringtonine across cell-based assays, animal models, and two early human cohorts, reporting inhibition of multiple coronaviruses and rapid SARS-CoV-2 clearance signals. Its main contribution is a cross-scale translational case for further investigation, although small, non-randomized patient groups and limited safety data prevent the findings from establishing clinical efficacy.

• Protease Inhibitor Cocktail: Product Overview

  2026-10-05

  K4001 is a supplier-described 50X DMSO protease inhibitor blend for conceptual protein degradation prevention during extraction, with no matched paper evidence available for product-specific performance.

• Five Questions About dNTPs and LNP Delivery

  2026-10-05

  A source-grounded guide to what a 10 mM dNTP mixture is, what recent LNP research actually shows, how strong the evidence is, and where interpretation must stop.

• HyperScribe™ Poly(A) Tailing: Research Context

  2026-10-04

  The HyperScribe™ Poly (A) Tailing Kit is described by APExBIO as an E. coli Poly (A) Polymerase-based reagent set for adding poly(A) tails to in vitro-transcribed RNA. This overview separates supplier claims from findings in a recent study of endosome-associated lc3b mRNA and local translation in neuronal axons. It explains where enzymatic polyadenylation may support conceptual expression and RNA-localization studies, while emphasizing that the supplied study did not validate this product, does not establish an optimal tail length, and cannot be used to infer clinical or therapeutic performance.

• Caspase-3 Fluorometric Assay Kit: From Signal to Mechanism

  2026-10-03

  The Caspase-3 Fluorometric Assay Kit provides a functional view of DEVD-dependent protease activity in apoptosis research. This article explains how to interpret fluorometric signals mechanistically, using renal cancer evidence to distinguish caspase activation from broader cell-death conclusions.

• Single-Molecule Screening of Fast-Dissociating Antibodies

  2026-10-02

  Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay that identifies specific antibodies with unusually rapid dissociation directly from hybridoma cultures. The resulting Fab probes supported multiplex super-resolution imaging and revealed rapid espin turnover within long-lived actin cores of inner-ear stereocilia, showing that fast exchange can be experimentally useful rather than simply a loss of affinity.

• CGP 55845 Hydrochloride in Synaptic Assays

  2026-10-01

  CGP 55845 hydrochloride provides a receptor-level control for separating GABAB signaling from astrocytic GAT-3 mechanisms in dentate gyrus experiments. This guide translates the reference study into practical in vitro neurotransmission assay workflows, dose-selection logic, controls, and troubleshooting strategies.

• Homoharringtonine Workflows for Cancer Research

  2026-10-01

  Homoharringtonine connects mechanistic leukemia research with emerging SARS-CoV-2 antiviral research through selective disruption of eukaryotic protein synthesis. This practical guide covers solvent handling, assay design, controls, cross-domain interpretation, and troubleshooting for reproducible bench workflows.

8173 records 1/545 page Next 12345 下5页 Last page